Abbott India Ltd

NSE: ABBOTINDIA BSE: 500488

₹26070

-225 (0.86%)

Thu, 22 Oct 2026, 05:58 pm

MTF 5xInvest in Abbott India Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)55983.41

PE Ratio34.31

Dividend1.99

Health Technology

Pharmaceuticals: Major

24.5K

Abbott India Ratios

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Price to earnings ratio	18.85	13.70	11.47	9	12.90	31.89	25.78	21.81	23.12	36.64	39.19	35.63	28.86	34.43	55.39	46.11	47.09	49.43	47.67	46.17
Price to book ratio	5.15	3.34	3.34	2.43	3.68	5.87	5.70	4.88	4.73	8.95	8.37	7.11	6.84	7.72	13.51	12.24	13.34	14.72	15.48	15.43
Price to sales ratio	2.51	1.61	1.32	0.85	1.31	1.96	2.15	1.92	2.04	3.71	3.83	3.40	3.51	4.22	8.03	7.39	7.66	8.77	9.79	10.19
Price to cash flow ratio	25.11	19.90	25.68	6.09	23.22	34.41	77.70	25.30	19.94	33	33.60	27.21	53.72	26.29	44.01	39.19	37.02	47.16	42.22	57.42
Enterprise value	1108Cr	808Cr	769Cr	403Cr	824Cr	1605Cr	2845Cr	2832Cr	3262Cr	7746Cr	9164Cr	8766Cr	10548Cr	13821Cr	30819Cr	29593Cr	35013Cr	45108Cr	55207Cr	62363Cr
Enterprise value to EBITDA ratio	14.74	11.47	9.57	5.11	8.46	24.90	19.17	14.78	15.84	26.01	24.50	21.64	19.56	22.28	39.69	31.55	31.81	36.71	37.37	36.18
Debt to equity ratio	0.01	0.01	0	0	0	0	0	0	0	0	0	0	0	0	0.07	0.06	0.05	0.04	0.02	0.05
Return on equity %	29.24	25.90	28.70	27.80	31.46	19.50	28.34	24.30	22.46	26.54	23.93	21.42	26.06	24.33	26.71	27.44	29.46	31.60	34.88	35.66

Abbott India Ltd Ratios

The Abbott India Ltd Ratios page provides a complete fundamental analysis of Abbott India Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Abbott India Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Abbott India Ltd (NSE: ABBOTINDIA, BSE: 500488) is currently trading at ₹26070, with a market capitalization of ₹55983.41Cr. As a major player in the Health technology sector and Pharmaceuticals: major industry, Abbott India Ltd remains a key stock for fundamental analysis using Abbott India Ltd Ratios.

Abbott India Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Abbott India Ltd P/E ratio currently stands at 46.17, making it one of the most tracked metrics in Abbott India Ltd Ratios.

Historically, the Abbott India Ltd P/E ratio has shown strong fluctuations:

2025: 46.17
2024: 47.67
2023: 49.43
2022: 47.09
2021: 46.11

The decline in Abbott India Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Abbott India Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 15.43.

Historical P/B trend:

2025: 15.43
2024: 15.48
2023: 14.72
2022: 13.34

Abbott India Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Abbott India Ltd P/S ratio currently stands at 10.19, an important part of Abbott India Ltd Ratios for revenue valuation.

Historical P/S ratio:

2025: 10.19
2024: 9.79
2023: 8.77
2022: 7.66

The rising Abbott India Ltd P/S ratio indicates improved revenue valuation by investors.

Abbott India Ltd Price to Cash Flow Ratio (P/CF)

The Abbott India Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 57.42.

Historical Abbott India Ltd Price to Cash Flow Ratio:

2025: 57.42
2024: 42.22
2023: 47.16
2022: 37.02
2021: 39.19

The rising Abbott India Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Abbott India Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Abbott India Ltd EV currently stands at ₹62363Cr, representing the total company valuation including debt.

Historical EV trend:

2025: 62363Cr
2024: 55207Cr
2023: 45108Cr
2022: 35013Cr

Abbott India Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Abbott India Ltd EV/EBITDA ratio is currently 36.18, a key metric in Abbott India Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

2025: 36.18
2024: 37.37
2023: 36.71
2022: 31.81

Stable Abbott India Ltd EV/EBITDA indicates balanced valuation.

Abbott India Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Abbott India Ltd D/E ratio is currently 0.05, reflecting leverage and financial stability.

Historical D/E:

2025: 0.05
2024: 0.02
2023: 0.04
2022: 0.05

Abbott India Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Abbott India Ltd ROE currently stands at 35.66%, showing profitability and capital efficiency.

Historical ROE:

2025: 35.66
2024: 34.88
2023: 31.60
2022: 29.46

Abbott India Ltd demonstrates strong profitability and efficient capital utilization.

Abbott India Ltd Ratios Analysis Summary

The Abbott India Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Abbott India Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Abbott India Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.